California May Regulate and Restrict Pharmaceutical Brokers

SACRAMENTO, Calif. — California Gov. Gavin Newsom will soon decide whether the most populous U.S. state will join 25 others in regulating the middlemen known as pharmacy benefit managers, or PBMs, whom many policymakers blame for the soaring cost of prescription drugs. PBMs have been under fire for years for alleged profiteering and anticompetitive conduct,…

Read More

The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains

Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S. Untangling the sprawling, global supply chain will be complicated and expensive, and could inadvertently compete with other administration goals regarding drug pricing and availability. The post The Myth of All-American Drugs and What Trump’s Tariffs Miss About…

Read More

Medicare Spending was 27% More for People who Disenrolled from Medicare Advantage than Similar People in Traditional Medicare

This analysis looks at traditional Medicare spending among people who choose to disenroll from Medicare Advantage and obtain coverage under traditional Medicare during the annual Medicare open enrollment period. It compares their traditional Medicare spending (Parts A and B) in the year following disenrollment to similar people who were continuously covered by traditional Medicare, using…

Read More